Additionally, various T cell-based active transfer NMO pathology models have been investigated, including the administration of NMO-IgG alongside experimental autoimmune encephalomyelitis (EAE) or the transfer of encephalogenic AQP4-specific T cells6,7. This evidence concerns the gene AQP4 and neuromyelitis optica.